Continuum in HIV care from entry to ART initiation in rural KwaZulu-Natal, South Africa

Tropical Medicine and International Health

Volumn 19, Issue 6, 2014, Pages 680-689

  Plazy, Mélanie ^a   Dray Spira, Rosemary ^b,c   Orne Gliemann, Joanna ^a   Dabis, François ^a   Newell, Marie Louise ^d,e  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Adults; Antiretroviral agents therapeutic use; Continuity of patient care; HIV; Rural health services; South Africa

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PATIENT CARE; RURAL AREA; SEX DIFFERENCE; SOUTH AFRICA; SURVIVAL TIME; TIME TO TREATMENT; YOUNG ADULT;

EID: 84899925903     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12301     Document Type: Article

References (40)

1. Aliyu MH, Blevins M, Parrish DD et al. (2014) Risk factors for delayed initiation of combination antiretroviral therapy in rural North Central Nigeria. Journal of Acquired Immune Deficiency Syndromes 1, e41-e49.
2. Bassett IV, Regan S, Chetty S et al. (2010) Who starts antiretroviral therapy in Durban, South Africa? not everyone who should. AIDS 24(Suppl. 1), S37-S44.
3. Bor J, Herbst AJ, Newell ML & Barnighausen T (2013) Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science 339, 961-965.
4. Clouse K, Pettifor AE, Maskew M et al. (2012) Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary healthcare clinic in Johannesburg, South Africa. Journal of Acquired Immune Deficiency Syndromes 1, e39-e46.
5. Duff P, Kipp W, Wild TC, Rubaale T & Okech-Ojony J (2010) Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western Uganda. Journal of the International AIDS Society 13, 37.
6. Faal M, Naidoo N, Glencross DK, Venter WD & Osih R (2011) Providing immediate CD4 count results at HIV testing improves ART initiation. Journal of Acquired Immune Deficiency Syndromes 58, e54-e59.
7. Fairall LR, Bachmann MO, Louwagie GM et al. (2008) Effectiveness of antiretroviral treatment in a South African program: a cohort study. Archives of Internal Medicine 168, 86-93.
8. Feldacker C, Johnson D, Hosseinipour M, Phiri S & Tweya H (2012) Who starts? Factors associated with starting antiretroviral therapy among eligible patients in two, public HIV clinics in Lilongwe, Malawi. PLoS One 7, e50871.
9. Fox MP, Mazimba A, Seidenberg P, Crooks D, Sikateyo B & Rosen S (2010) Barriers to initiation of antiretroviral treatment in rural and urban areas of Zambia: a cross-sectional study of cost, stigma, and perceptions about ART. Journal of the International AIDS Society 13, 8.
10. Gargano JW, Laserson K, Muttai H et al. (2012) The adult population impact of HIV care and antiretroviral therapy in a resource poor setting, 2003-2008. AIDS 26, 1545-1554.
11. Geng EH, Bwana MB, Muyindike W et al. (2013) Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda. Journal of Acquired Immune Deficiency Syndromes 63, e64-e71.
12. Govindasamy D, van Schaik N, Kranzer K, Wood R, Mathews C & Bekker LG (2011) Linkage to HIV care from a mobile testing unit in South Africa by different CD4 count strata. Journal of Acquired Immune Deficiency Syndromes 58, 344-352.
13. Govindasamy D, Ford N & Kranzer K (2012) Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS 26, 2059-2067.
14. Herbst AJ, Cooke GS, Barnighausen T, KanyKany A, Tanser F & Newell ML (2009) Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bulletin of the World Health Organization 87, 754-762.
15. Hermans SM, van Leth F, Manabe YC, Hoepelman AI, Lange JM & Kambugu A (2012) Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study. HIV Medicine 13, 337-344.
16. Horstmann E, Brown J, Islam F, Buck J & Agins BD (2010) Retaining HIV-infected patients in care: Where are we? Where do we go from here? Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 50, 752-761.
17. Horvath T, Azman H, Kennedy GE & Rutherford GW (2012) Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection. Cochrane Database Systematic Review 3, CD009756.
18. Houlihan CF, Bland RM, Mutevedzi PC et al. (2011) Cohort profile: Hlabisa HIV treatment and care programme. International journal of epidemiology. 40, 318-326.
19. Iwuji CC, Mayanja BN, Weiss HA et al. (2011) Morbidity in HIV-1-infected individuals before and after the introduction of antiretroviral therapy: a longitudinal study of a population-based cohort in Uganda. HIV Medicine 12, 553-561.
20. Jani IV, Sitoe NE, Alfai ER et al. (2011) Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet 378, 1572-1579.
21. Johnson L (2012) Access to antiretroviral treatment in South Africa, 2004-2011. The Southern African Journal of HIV Medicine 13, 23-27.
22. Kasamba I, Baisley K, Mayanja BN, Maher D & Grosskurth H (2012) The impact of antiretroviral treatment on mortality trends of HIV-positive adults in rural Uganda: a longitudinal population-based study, 1999-2009. Tropical Medicine & International Health: TM & IH 17, e66-e73.
23. Kranzer K, Zeinecker J, Ginsberg P et al. (2010) Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa. PLoS One 5, e13801.
24. Larson BA, Brennan A, McNamara L et al. (2010) Lost opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South Africa. Bulletin of the World Health Organization 88, 675-680.
25. Larson BA, Schnippel K, Ndibongo B et al. (2012) Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa. Journal of Acquired Immune Deficiency Syndromes 61, e13-e17.
26. Larson BA, Schnippel K, Brennan A et al. (2013) Same-day CD4 testing to improve uptake of HIV care and treatment in South Africa: point-of-care is not enough. AIDS Research and Treatment 2013, 941493.
27. Lawn SD, Harries AD, Anglaret X, Myer L & Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22, 1897-1908.
28. Lessells RJ, Mutevedzi PC, Cooke GS & Newell ML (2011) Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. Journal of Acquired Immune Deficiency Syndromes 56, e79-e86.
29. Lessells RJ, Mutevedzi PC, Iwuji CC & Newell ML (2014) Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4+ cell count eligibility criteria. Journal of Acquired Immune Deficiency Syndromes 65, e17-e24.
30. Moh R, Danel C, Messou E et al. (2007) Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa. AIDS 21, 2483-2491.
31. Mugglin C, Estill J, Wandeler G et al. (2012) Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Tropical Medicine & International Health: TM & IH 17, 1509-1520.
32. Mwai GW, Mburu G, Torpey K, Frost P, Ford N & Seeley J (2013) Role and outcomes of community health workers in HIV care in sub-Saharan Africa: a systematic review. Journal of the International AIDS Society 16, 18586.
33. Rosen S & Fox MP (2011) Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Medicine 8, e1001056.
34. South African National Department of Health (2010) Clinical guidelines for the management of HIV and AIDS in adults and adolescents. http://www.sahivsoc.org/upload/documents/Clinical_Guidelines_for_the_Management_of_HIV_AIDS_in_Adults_Adolescents_2010.pdf
35. UNAIDS (2012) Global Report: UNAIDS report on the global AIDS epidemic. http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_en.pdf
36. UNAIDS (2013) Global report: UNAIDS report on the global AIDS epidemic 2013. http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf
37. Walensky RP, Wolf LL, Wood R et al. (2009) When to start antiretroviral therapy in resource-limited settings. Annals of Internal Medicine 151, 157-166.
38. WHO (2010) Antiretroviral therapy for HIV infection in adults and adolescents. Recommandations for a public health approach (revision). http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf
39. WHO (2013) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf
40. Zaidi J, Grapsa E, Tanser F, Newell ML & Barnighausen T (2013) Dramatic increase in HIV prevalence after scale-up of antiretroviral treatment. AIDS 27, 2301-2305.